Vlad Herta is an associate in our corporate practice where he counsels clients on a range of matters, with an emphasis on equity capital markets transactions and cross-border mergers and acquisitions, including SPACs. Vlad advises a range of public and private companies across multiple industries, with a focus on the tech and life sciences sectors.

Download full bio 


  • Redx Pharma to Merge With Jounce Therapeutics 

  • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 


  • New York University School of Law
    JD, 2018

  • Hitotsubashi University
    LLB, Economics
    Japanese government scholar, 2014

Admissions & Credentials

New York